Cefotaxime (C) vs cefotaxime + amikacin (C + A) in the treatment of septicemia due to enterobacteria: a multicenter study.
Carbon
C
C
Hôpitaux de Paris, France.
Auboyer
C
C
Becq-Giraudon
B
B
Bertrand
P
P
Gallais
H
H
Mouton
Y
Y
Motin
J P
JP
Vachon
F
F
Wasmer
J M
JM
Buré
A
A
D000583:Amikacin / Q000627:therapeutic use*; D002439:Cefotaxime / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004755:Enterobacteriaceae / Q000302:isolation & purification; D004756:Enterobacteriaceae Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D018805:Sepsis / Q000188:drug therapy* / Q000209:etiology
D000583:Amikacin; D002439:Cefotaxime